Infected Blood Inquiry

Read the latest news on the Public
Inquiry into Contaminated Blood

The taintedblood Timeline  -  what really happened...

"To no one will we sell, to no one deny or delay, right or justice."
Magna Carta - 15th June, 1215

 
No of entries selected: 9 of 711
1968
Krever Report - Hepatitis B Surface Antigen Test Developed
In 1968, a direct test for the presence of Hepatitis B (HBsAg), (Hepatitis B Surface Antigen) is developed and used to identify persons with the disease.
Source: Krever Commission Report (1997), Vol 3, Part IV, Chap. 27, page 753
Type: Testing development
Location: USA
Find related entries
1970
(early)
Lister Institute of Preventative Medicine
In the early 1970s it becomes clear that the world-renowned Lister Institute is not holding its own financially.
Source:
Type: Historical statement
Location: UK
Find related entries
1971
November
Hepatitis B Screening Becomes Available
Screening for Hepatitis B becomes available.

Note: The screening of donated plasma for hepatitis B, (HBV) is introduced by BPL in November 1971.

Source: Self-sufficiency in Blood Products in England and Wales - A Chronology from 1973-1991. DOH (2006).
Notes from Regional Transfusion Directors meeting. 10th January 1973.
Type: Screening development - HBV. Taken from DOH Self-sufficiency Report
Location: UK
Find related entries
1975
Lister Institute of Preventative Medicine
The Lister Institute of Preventative Medicine Chelsea laboratories are forced to close due to repeated annual deficits and failure to secure adequate government support.

Astonishingly, the government stopped funding the only research facility that could have developed heat-treatment and a screening test for Non-A Non-B hepatitis by as early as 1978.

Source:
Type: Scientific Heritage Historical statement
Location: UK
Find related entries
1977
2 February
DHSS - Fate of Floundering Lister Institute
In a DHSS letter of 2nd February 1977, a viability study of the world-renowned Lister Institute is discussed. The letter states that a conclusion has been reached:

"the Department should not on financial grounds make a loan or grant to [Lister?] and that the possible consequences of [Lister?] ceasing to produce sera and vaccines should be accepted". (Paragraph 1, lines 3-5)

"Nevertheless we should be faced with very real difficulties if [Lister?] were to be wound up" (Line 4 of paragraph 3)

"Any disruption in production during this interim period, which could well arise if we were forced to act too quickly, would probably cause clinicians to fall back on commercial suppliers of blood products, thus adding to the total cost of the NHS as well as inducing a setback for Ministers' policy of UK self-sufficiency in blood products production" (Last 6 lines of paragraph 3)

Note: This situation ended up with the Lister Institute's Elstree Lab closing in 1978 due to repeated annual deficits coupled with the need for major expenditure in order to modernise the production facilities. The Lister Institute was well-poised to possibly go on to develop heat-treatment or even a test for NANBH by as early as 1978 - if only the Government had made that loan or grant.

Source:
Type: Recovered Document - DHSS Letter
Location: UK
Find related entries
1978
Sunday Observer Timeline - Test for Viral Hepatitis in Blood Donors
A test is developed to determine a history of viral hepatitis in blood donors.
Source: Link #1
Type: Press timeline
Location: UK
Find related entries
1978
New Hepatitis B Core (HBc) Test
By no later than 1978, the US Pharmaceuticals allegedly know of the availability of a new Hepatitis B Core (HBc) test that can determine whether an individual has a history of viral Hepatitis, which would disqualify the donor from providing plasma for the manufacture of Factor VIII or IX.
Source: MDL 986 Class Action Plaintiffs' Complaint (2004) LCHB, LLP Page 18
Type: Legal document (complaint)
Location: USA
Find related entries
1978
Lister Institute of Preventative Medicine, Elstree - Closure
Lister Institute Laboratory at Elstree closes due to repeated annual deficits coupled with the need for major expenditure in order to modernise the production facilities.

The Institutes' list of achievements are unprecedented in the field of medical science.

Source:
Type: Historical statement
Location: UK
Find related entries
1984
April
Armour, Cutter, Alpha, Baxter
The US Blood Companies finally introduce the Hepatitis B Core Antibody (HBc) test. This is late since the HBc test was reported to be an effective surrogate test for both AIDS transmission and Non-A non-B Hepatitis carriers by 1982.
Source: Class Action Complaint (2004) Case No. C032572 PJH Page 39
Type: Test introduction
Location: USA
Find related entries
Timeline Copyright ©2006 Andrew March & Haydn Lewis
All rights reserved

 

Telephone

07717471460

Follow

Address

7 Yessell Lane, Hinton-on-the-Green, Evesham, Worcestershire WR11 2RE

Terms & Conditions | Privacy | Website © Tainted Blood 2021